In the full cohort of 81 patients, increases were observed in nearly half of patients for FEV1 (49%) and FVC (46%), but results did not reach statistical significance.
← all excerpts
Safety and efficacy of tirzepatide in transplant recipients: a systematic review and meta-analysis.
1
—
—